do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance guideline The effect of DPP Role of DPP-4 Inhibitors in
Description
In non-human primates, the highest GLP-1 immunoreactivity has been demonstrated in various nuclei of the hypothalamus, the area postrema, the NTS, and the dorsal motor nucleus of the vagus [389]
Lancet 2009;374:160616
doi: 10.1016/j.atherosclerosis.2017.04.001 131 PoulterNRPrabhakaranDCaulfieldM
Varol C, Zvibel I, Spektor L, Mantelmacher FD, Vugman M, Thurm T, et al
Jall S, Sachs S, Clemmensen C, Finan B, Neff F, DiMarchi RD, et al
New GLP-1 drugs keep arriving, with the same active ingredient often appearing under multiple brand names at different doses
